InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by Hasnain Faheem, Président et CEO. Director active across 2 companies, notably Mirati Therapeutics, Inc.. Aggregated, 3 disclosures have been published. Total volume traded: €154k. The latest transaction was disclosed on 23 March 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations3 total
€153,85419,035 shares@ €8.08270.19% mcap100.0% of flow
Common Stock
SEC:0001728117-22-000031:0·
03,619 shares0
Common Stock
SEC:0001214659-22-000854·
03,619 shares0
Common Stock
SEC:0001214659-22-000854:0·
3 of 3 declarations
About Hasnain Faheem
Faheem Hasnain is the President and CEO of Mirati Therapeutics, Inc. and Gossamer Bio, Inc. He leads the strategic and commercial operations of both companies, focusing on innovation in the biotechnology field. With extensive experience in the pharmaceutical sector, he is responsible for strategic direction and growth. His leadership is essential for developing innovative treatments and improving patients' lives.
